Listeria Monocytogenes Infections Treatment Market Forecast 2024-2033: Growth Rate, Drivers, And Trends|Pfizer Inc., F. Hoffmann-La Roche AG, AbbVie Inc., Novartis AG, Sanofi S.A.

The Listeria Monocytogenes Infections Treatment Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Listeria Monocytogenes Infections Treatment Market:
https://www.thebusinessresearchcompany.com/report/listeria-monocytogenes-infections-treatment-global-market-report

According to The Business Research Company’s Listeria Monocytogenes Infections Treatment Global Market Report 2024, The listeria monocytogenes infections treatment market size has grown strongly in recent years. It will grow from $4.52 billion in 2023 to $4.79 billion in 2024 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to increased food safety regulations, increased incidence of foodborne illnesses, advancements in diagnostics, awareness programs and education, healthcare infrastructure development..

The listeria monocytogenes infections treatment market size is expected to see strongly grown in the next few years. It will grow to $5.86 billion in 2028 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to globalization of food supply chains, research and development in antimicrobials, changing dietary patterns, international collaboration in healthcare, public health preparedness.. Major trends in the forecast period include application of combination therapies, enhanced diagnostic tools, focus on prevention and prophylaxis, collaborative research initiatives, regulatory framework development..

The rising incidence of foodborne diseases is expected to propel the growth of the listeria monocytogenes infection treatment going forward. Foodborne diseases, also known as foodborne illnesses or food poisoning, refer to diseases caused by consuming contaminated food or beverages. Listeria monocytogenes infections caused by the bacterium Listeria monocytogenes, can be a significant concern in foodborne illnesses because this bacterium can contaminate various foods. The treatment for listeria monocytogenes infections reduces the risk factors and severity associated with the disease. For instance, in December 2022, according to the European Food Safety Authority, an Italy-based independent agency for providing scientific advice on food and feed safety, nutrition, and related issues, there were around 4,005 foodborne incidents in 2021, an increase of 29.8% compared to 2020. Therefore, the rising incidence of foodborne diseases is driving the growth of the listeria monocytogenes infection treatment.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=13092&type=smp

The listeria monocytogenes infections treatment market covered in this report is segmented –

1) By Drug Class: Ampicillin, Gentamicin, Vancomycin, Other Drug Classes
2) By Type Of Infection: Gastroenteritis, Endocarditis, Meningitis, Bacteremia, Brain Abscess
3) By Mode Of Administration : Oral, Injectable, Other Mode Of Administrations
4) By End Users: Hospitals, Home Care, Speciality Clinics, Other End Users

Major companies operating in the listeria monocytogenes infections treatment market are focusing on developing innovative products such as Microgen Listeria-ID to drive revenues in the market. Microgen Listeria-ID is a microbiological test designed to detect and confirm the presence of Listeria bacteria in food and other environmental samples. This comprehensive identification technique enables laboratories to identify and differentiate Listeria spp species without additional materials correctly. For instance, in April 2023, Gold Standard Diagnostics, a US-based company specializing in diagnostic test systems and services, launched Microgen Listeria-ID. The primary use of Microgen Listeria-ID is to identify Listeria monocytogenes for quality control and monitoring purposes in food processing facilities. Microgen Listeria-ID is known for its rapid and reliable identification of Listeria species. It can provide results in a shorter time compared to traditional culture-based methods.

The listeria monocytogenes infections treatment market report table of contents includes:

1. Executive Summary
2. Listeria Monocytogenes Infections Treatment Market Characteristics
3. Listeria Monocytogenes Infections Treatment Market Trends And Strategies
4. Listeria Monocytogenes Infections Treatment Market – Macro Economic Scenario
5. Global Listeria Monocytogenes Infections Treatment Market Size and Growth

.

.

.

32. Global Listeria Monocytogenes Infections Treatment Market Competitive Benchmarking
33. Global Listeria Monocytogenes Infections Treatment Market Competitive Dashboard
34. Key Mergers And Acquisitions In Listeria Monocytogenes Infections Treatment Market
35. Listeria Monocytogenes Infections Treatment Market Future Outlook and Potential Analysis
36. Appendix

 

Top Major Players :

• Pfizer Inc.
• Hoffmann-La Roche AG
• AbbVie Inc.
• Novartis AG
• Sanofi S.A.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model